1 IND 19736 185 23 Feb 2021 KERRY KERRY RO

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

2

Document text

sϰͺϮϬϭϵϭϭϬϳͺ>, WĂŐĞϭŽĨϮ2IILFH RI %LRVWDWLVWLFV DQG (SLGHPLRORJ\'LYLVLRQ RI (SLGHPLRORJ \
3HULRGLF 6DIHW\ 5HSRUW 5HYLHZ &KHFNOLVW
&RPSOHWHG E\ 5HYLHZHU
3URGXFW 1DPH
0DQXIDFWXUHU
671 
'&& /RJLQ ,' 
6XEPLVVLRQ 7\SH 3$(5 3685
3%5(5 3$'(5
6XEPLVVLRQ )RUPDW (/(&7521,&
3$3(5
5HSRUWLQJ 3HULRG )520
72
'DWH 5HFHLYHG E\ )'$
'DWH 5RXWHG WR 5HYLHZHU
5HJXODWRU\ ,QIRUPDWLRQ 6SHFLDOLVW 5,6  1DPH
5HYLHZHU  1DPH
5HYLHZHU 6LJQDWXUH
HOHFWURQLF VLJQDWXUH
&200(1763IL]HU%LR17HFK &29,' 9DFFLQH
3IL]HU
,1'



5DPDFKDQGUD 1DLN
.HUU\ :HOVK✔


Kerry J. Welsh -SDigitally signed by Kerry J. Welsh -S 
DN: c=US, o=U.S. Government, ou=HHS, ou=FDA, ou=People, cn=Kerry J. Welsh -S, 0.9.2342.19200300.100.1.1=2001896608 Date: 2021.02.23 10:36:17 -05'00'
FDA-CBER-2021-5683-1150396
5HIHUHQFH'RFXPHQWV;?'(?0(',&$/2)),&(5?*XLGDQFH'RFXPHQWV
 (&&OLQLFDO 6DIHW\'DWD0DQDJHPHQW3HULRGLF6DIHW\8SGDWH5HSRUWVIR U0DUNHWHG'UXJV
Ϯ͘$GGHQGXPWR(&6DIHW\'DWD0DQDJHPHQW3HULRGLF6DIHW\8SGDWH5HSRUWVIR U0DUNHWHG'UXJV
sϰͺϮϬϭϵϭϭϬϳͺ>, WĂŐĞϮŽĨϮ2IILFH RI %LRVWDWLVWLFV DQG (SLGHPLRORJ\'LYLVLRQ RI (SLGHPLROR J\
3HULRGLF 6DIHW\ 5HSRUW 5HYLHZ &KHFNOLVW
 &RXQWULHV ZKHUH WKH SURGXFW LV OLFHQVHG RU DXWKRUL]HG IRU GLVWULEXWL RQ
1RW 5HSRUWHG 86 :RUOGZLGH
 (VWLPDWHG QXPEHU RI GRVHV GLVWULEXWHG E\UHSRUWLQJ SHULRGFXPXO DWLYH
1RW5HSRUWHG 86
:RUOGZLGH1RW $SSOLFDEOH
 'RHV WKLV UHSRUW GHVFULEH DQ\DFWLRQV WDNHQ E\WKH PDQXIDFWXU HU RU RWKHU UHJXODWRU\DJHQF\ IRU
WKLV SURGXFW HJ ODEHOLQJ FKDQJHV" <HV 1R
 +DYH WKHUH EHHQ DQ\QHZ VDIHW\LVVXHV LGHQWLILHG E\WKH UHYLHZHU LQ WKLV 3685" <HV 1R
,I <(6 SOHDVH SURYLGH SHUWLQHQW LQIRUPDWLRQ EHORZ $1' QRWLI\GL VFXVV VDIHW\LVVXHV ZLWK WKH 7HDP /HDG
DQGRU %UDQFK &KLHI
&RQFOXVLRQV
7KH FRQWHQWV RI WKLV 36853$(5 GR QRW LQGLFDWH D QHHG IRU IXUWK HU UHJXODWRU\ DFWLRQ
3OHDVH VHH WKH IROORZLQJ FRPPHQWV DQG UHFRPPHQGDWLRQV4 7KH (8$ )DFW 6KHHW IRU +HDOWKFDUH 3URIHVVLRQDOV DQG (8$ SUHVFULELQJ LQIRUPDWLRQ ZHUH XSGDWHG
'HFHPEHU   WR DGG ZDUQLQJV WR PRQLWRU YDFFLQH UHFLSLHQWV IRU WKH RFFXUUHQFH RI LPPHGLDWHDGYHUVH UHDFWLRQV4 7KH IROORZLQJ VLJQDOV ZHUH HYDOXDWHGL $QDSK\OD[LV FRQVLGHUHG DQ ,PSRUWDQW ,GHQWLILHG 5LVN WKDW ZDV DGGHG WR WKH 393 DQG (8$ )DFW 6KHHWLL ,QMHFWLRQ VLWH UHGQHVV ,QMHFWLRQ VLWH VZHOOLQJ 0DODLVH DQG 1DXVHD FORVHG DV ,GHQWLILHG 5LVNV 1RW,PSRUWDQW 5HYLHZHU FRPPHQW 7KHVH $(V DUH LQFOXGHG LQ WKH (8$ )DFW 6KHHW 
LLL 9RPLWLQJ DQG 'LDUUKHD &ORVHG DV 1R 5LVNVLY 7KH IROORZLQJ DUH XQGHU HYDOXDWLRQ DV VLJQDOV +\SHUVHQVLWLYLW\ QRW $QDSK\OD[LV ,QVRPQLD ,QMHFWLRQVLWH SUXULWXV 3DLQ LQ WKH H[WUHPLW\ DQG )DFLDO SDUDO\VLV 5HYLHZHU FRPPHQW %HOO
V SDOV\ LV LQFOXGHG LQWKH (8$ )DFW 6KHHW $ UHFHQW ODEHO XSGDWH LQFOXGHV K\SHUVHQVLWLYLW\ UHDFWLRQV (8$
✔✔
✔✔ ✔
GRVHV
 GRVHV
(b) (4)
FDA-CBER-2021-5683-1150397